Inquiry Basket
Loading ......
Filter By Product Search for
HIV tat
HIV tat Full Name
human immunodeficiency virus tat
HIV tat Introduction
HIV-1 Tat (Trans-Activator of Transcription) is a small but essential regulatory protein that drives efficient transcription of the viral genome. Its primary function is to bind the trans-activation response (TAR) RNA element located at the 5′ end of nascent viral transcripts and recruit the host transcriptional elongation factor P-TEFb, composed of CDK9 and cyclin T1. This interaction enables phosphorylation of the RNA polymerase II (Pol II) C-terminal domain, converting short, abortive transcripts into full-length viral RNAs. Through this mechanism, Tat establishes a powerful positive feedback loop that amplifies transcription from the HIV long terminal repeat (LTR), ensuring robust viral gene expression. Structurally and functionally, Tat operates as a molecular bridge between viral RNA and host transcription machinery, coordinating transcriptional elongation, promoter activation, and chromatin accessibility. This central role makes the Tat–TAR–P-TEFb axis a cornerstone of HIV replication and a critical control point in viral gene expression.
Beyond its canonical transcriptional role, Tat interacts with a wide range of host cellular factors, including transcription factors and chromatin-modifying enzymes such as p300/CBP, PCAF, and NF-κB. These interactions enable Tat to remodel chromatin structure, enhance promoter accessibility, and regulate both viral and host gene expression. Tat-mediated recruitment of histone acetyltransferases promotes a transcriptionally active chromatin environment at the HIV promoter, while additional interactions influence signaling pathways that extend beyond viral transcription. Importantly, Tat is not confined to infected cells; it can be released into the extracellular environment and taken up by neighboring cells, where it alters gene expression, cytokine production, and cellular behavior. These bystander effects contribute to HIV-associated pathologies, including chronic inflammation, immune dysregulation, and neurological complications. Furthermore, Tat can modulate transcription of other viral genomes in co-infected cells, highlighting its broader regulatory capacity in complex infection settings.
Tat plays a pivotal role in HIV latency and reactivation, making it a key target for therapeutic intervention. In latent infection, insufficient Tat expression limits transcriptional elongation, maintaining viral silence; conversely, reintroduction or activation of Tat can trigger viral reactivation by restoring P-TEFb recruitment and transcriptional activity. This duality underpins current cure strategies, including "shock and kill" approaches that aim to reactivate latent reservoirs and eliminate infected cells, as well as "block and lock" strategies designed to suppress Tat function and maintain long-term latency. Therapeutic approaches targeting Tat include small molecules that disrupt Tat–TAR binding or Tat–P-TEFb interactions, antisense and RNA interference strategies that reduce Tat expression, and peptide-based inhibitors that interfere with its regulatory functions. However, the multifunctional nature of Tat—including its extracellular effects and involvement in host transcriptional networks—adds complexity to therapeutic design. Overall, HIV-1 Tat represents a master regulator of viral transcription and a multifunctional mediator of host–virus interactions, with ongoing research focused on leveraging its unique properties to develop more effective antiviral and curative strategies.
Alternate Names for HIV tat
p14; Tat; Tat protein; Transactivating regulatory protein; HIV tat
Loading ......
